GOWEN MAXINE

CIK 00012800448 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001280044

Recent Transactions

50 trades

Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−13,193→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−12,240→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−14,414→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−7,957→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−16,604→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−8,844→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-06−4,793→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-06-06+4,793→ 21,754 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2025-06-05+42,350→ 42,350 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-05+11,580→ 11,580 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (right to buy)
2025-05-28+201,857→ 201,857 total
Award
Merus N.V.$MRUS
Share Option (right to buy)
2025-05-22+13,193→ 13,193 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2024-06-06+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-06+4,793→ 4,793 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-06-01+4,660→ 16,961 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-01−4,660→ 0 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (right to buy)
2024-05-21+47,693→ 47,693 total
Award
Merus N.V.$MRUS
Share Option (right to buy)
2024-05-07+8,844→ 8,844 total
Sale
Aceragen, Inc.
Common Stock
2023-08-10$0.51/sh−51→ 0 total
Award
Merus N.V.$MRUS
Share option (right to buy)
2023-06-08+14,414→ 14,414 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-02+4,507→ 12,301 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-02−4,507→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2023-06-01+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-01+4,660→ 4,660 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (Right to Buy)
2023-05-25+24,000→ 24,000 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2022-06-23+26,000→ 26,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 7,794 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Merus N.V.$MRUS
Share option (right to buy)
2022-05-31+16,604→ 16,604 total
Award
Passage BIO, Inc.$PASG
Stock Option (Right to Buy)
2022-05-31+40,000→ 40,000 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (Right to Buy)
2022-05-26+24,000→ 24,000 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2021-06-08+26,000→ 26,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2021-06-03+12,250→ 12,250 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-06-03+3,356→ 3,356 total
Award
Merus N.V.$MRUS
Share option (right to buy)
2021-05-28+12,240→ 12,240 total
Award
Merus N.V.$MRUS
Share option (right to buy)
2021-05-28+12,240→ 12,240 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (Right to Buy)
2021-05-27+4,542→ 4,542 total
Award
Passage BIO, Inc.$PASG
Stock Option (right to buy)
2021-02-18+33,836→ 33,836 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2020-06-08$12.05/sh−4,567→ 24,133 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2020-06-05+13,700→ 28,700 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2020-06-05+20,100→ 20,100 total
Award
Aclaris Therapeutics, Inc.$ACRS
Option Grant (right to buy)
2020-06-04+16,500→ 16,500 total
Award
TREVENA INC
Stock Option (Right to Buy)
2020-05-13+64,103→ 64,103 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2020-05-12+11,500→ 11,500 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02−4,438→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02+4,438→ 4,438 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-03-02+4,438→ 4,438 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2019-07-02+16,000→ 16,000 total

Companies

Recent Filings

Address

14200 SHADY GROVE ROAD

ROCKVILLE, MD, 20850

View on SEC.gov